Multiple Myeloma: Risk Adapted Use of Plerixafor for Stem Cell Mobilization Prior to Autologous Stem Cell Transplantation is Effective and Cost Efficient

Autor: Prakash, Vadlamani Surya, Malik, Prabhat Singh, Sahoo, Ranjit Kumar, Pramanik, Raja, Choudhary, Priyanshu, Varshney, Ankur Nandan, Kumar, Lalit
Zdroj: In Clinical Lymphoma, Myeloma and Leukemia January 2022 22(1):44-51
Databáze: ScienceDirect